These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23324758)

  • 1. Retrospective analysis of tissue plasminogen activator as an adjuvant treatment for calciphylaxis.
    el-Azhary RA; Arthur AK; Davis MD; McEvoy MT; Gibson LE; Weaver AL; Camilleri MJ; Wetter DA; Weenig RH
    JAMA Dermatol; 2013 Jan; 149(1):63-7. PubMed ID: 23324758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose tissue plasminogen activator for calciphylaxis.
    Sewell LD; Weenig RH; Davis MD; McEvoy MT; Pittelkow MR
    Arch Dermatol; 2004 Sep; 140(9):1045-8. PubMed ID: 15381542
    [No Abstract]   [Full Text] [Related]  

  • 5. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
    Simon JE; Sandler DL; Pexman JH; Hill MD; Buchan AM;
    Age Ageing; 2004 Mar; 33(2):143-9. PubMed ID: 14960429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of delivering recombinant tissue plasminogen activator on a new infusion system during endovascular intervention in patients with lower limb ischemia.
    Yuan B; Li T; Zhang Y; Zhang W; Ren T; Yang B
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):445-52. PubMed ID: 23344769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing early results and complication rates of the thrombolytic treatment of lower limb ischemia with recombinant tissue-type plasminogen activator.
    Asciutto G; Geier B; Marpe B; Hummel T; Mumme A
    Chir Ital; 2006; 58(5):597-604. PubMed ID: 17069188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of tissue plasminogen activator to treat intracardiac thrombosis in extremely low-birth-weight infants.
    Bose J; Clarke P
    Pediatr Crit Care Med; 2011 Nov; 12(6):e407-9. PubMed ID: 21131893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
    Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
    Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
    J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator.
    Wang CT; Lin FC; Khor GT; Chen CH; Huang P
    Am J Emerg Med; 2012 Jan; 30(1):253.e1-2. PubMed ID: 21109385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-accelerated versus standard catheter-directed thrombolysis in 102 patients with acute and subacute limb ischemia.
    Schernthaner MB; Samuels S; Biegler P; Benenati JF; Uthoff H
    J Vasc Interv Radiol; 2014 Aug; 25(8):1149-56; quiz 1157. PubMed ID: 24933285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis.
    McCarthy JT; El-Azhary RA; Patzelt MT; Weaver AL; Albright RC; Bridges AD; Claus PL; Davis MD; Dillon JJ; El-Zoghby ZM; Hickson LJ; Kumar R; McBane RD; McCarthy-Fruin KA; McEvoy MT; Pittelkow MR; Wetter DA; Williams AW
    Mayo Clin Proc; 2016 Oct; 91(10):1384-1394. PubMed ID: 27712637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.